|
NPCE Neuropace Inc 1528287 |
| Balance Sheet |
|
Current Assets
|
$86,193,000.00 |
|
Assets
|
$96,991,000.00 |
|
Current Liabilities
|
$17,433,000.00 |
|
Liabilities
|
$85,108,000.00 |
|
Equity
|
$11,883,000.00 |
|
Shares Out
|
34282567.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-9,803,000.00 |
|
Investing Cash Flow
|
$-242,000.00 |
| Market Analysis |
Market Cap
|
$480,641,589.34 |
|
Price
|
$14.02 |
|
BVPS
|
0.35 |
|
PB
|
40.06 |
|
EPS
|
-0.18 |
|
PS
|
5.26 |
|
FCF
|
$-10,045,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:39 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:30 |
|
| Apr |
May |
Jun |
| 2026-03-03 |
-0.08 |
|
|
2026-05-12 |
-0.20 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-12 |
-0.26 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-04 |
-0.11 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view NPCE documents filed with the SEC.
NPCE Filings
Clear
